Page 2 - University of Oxford

Arthritis & Rheumatism

New breakthrough in the treatment of rheumatoid arthritis

People with Rheumatoid Arthritis (RA) could soon benefit from a new drug treatment that not only suppresses inflammation but also significantly reduces patient reported pain scores. Otilimab is a monoclonal antibody, biologic ...

Diseases, Conditions, Syndromes

First trial of a new hepatitis C vaccine shows promise

(Medical Xpress) -- A new vaccine against the chronic liver disease hepatitis C has shown promising results in a first clinical trial in humans, Oxford University researchers report.

page 2 from 40